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Abstract
The area of remote monitoring in cardiac failure is developing rapidly. However, the term is used
widely and inconsistently, resulting in difficulty interpreting the literature. Here we assess the recent
research into this area and the potential implications for clinical practice.
Introduction and context
Remote monitoring can be summarized as the contin-
uous collection of patient information and the capability
to review this information without the patient present. It
may refer to data collected through patient contact, as in
telemonitoring, or to data collected through telemetry of
a device.
Remote monitoring of patients with chronic disease is an
emerging area of health care behaviour. Consistent with
contemporary health care policy it aims to provide care
to the patient in their home and empower them for self-
care. The term remote monitoring is used widely to refer
to a variety of models: structured telephone support,
remote monitoring of physiological parameters or
implantable devices capable of remote patient monitor-
ing and management. Whilst there are distinct differ-
ences in these models, they all use information
communication technology to monitor the patients’
clinical status without face-to-face contact. They focus
upon the delivery of care with the patient and health
professional separated by distance and emphasise care of
the patient in their home. The primary objectives of
remote monitoring are to reduce morbidity and detect
signs and symptoms of deterioration that might lead to
an unnecessary hospitalisation.
Recent advances
Reflecting the interest in these new models of disease
management, McAlister and colleagues [1] updated their
earlier systematic review of chronic disease management
for patients with heart failure. Grouping telephone and
telemonitoring studies together, they demonstrated that
these remote monitoring techniques lead to a reduction
in heart failure hospitalisations, but had no impact on
all-cause hospitalisation rate or mortality. More recently
Clark et al. [2] reviewed 14 studies involving 4,264
patients in a meta-analysis of remote monitoring, with
studies grouped into those that evaluated telemonitoring
or those that evaluated telephone support. They con-
firmed similar results across the models of remote
monitoring: a 20% reduction in mortality, a 21%
reduction in heart failure admission and no difference
in all-cause hospital admission when remote monitoring
was compared with usual care. They concluded that these
newer models of care offered patient advantage particu-
larly where patients had difficulty accessing specialised
care. However, these models of remote monitoring vary
considerably in the parameters they monitor and in the
involvement of both the patient and health professional,
and therefore require further analysis if we are to
understand their effective components.
Models of remote monitoring were initially developed
using the patients’ home phone line. Structured phone
support enables the patient to report their self-assess-
ment of symptoms and receive verbal advice and
education, usually on a monthly basis [3]. More complex
models enable the transfer of physiological data by the
patient inputting their data through a telephone touch-
pad [4]. Increasingly, remote monitoring involves the
home installation of simple to use electronic equipment
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and rhythm monitors to record vital signs linked to the
normal home phone-line. The patient uses the monitor-
ing on a daily basis. The clinical data is encrypted and
transmitted for professional review at a remote central
station [5,6]. As wireless technology develops, data
transfer is becoming possible without the need for a
direct phone connection.
More complex remote monitoring is now possible
through implantable devices that measure intra-thoracic
impedance or haemodynamic parameters using sensors
incorporated into the device. These devices are able to
provide early warning of impending clinical deteriora-
tion. They can be added to implantable pacing devices,
cardiac resynchronisation therapies (CRTs) or implan-
table cardioverter defibrillators (ICDs), and set to sound
an alarm when a preset threshold is exceeded. Interroga-
tion of the device then reveals clinical parameters
suggestive of fluid overload and early management can
be instituted. However, these devices remain the subject
of robust study and are currently being evaluated in
randomised clinical trials. In fact, the 2008 European
Society of Cardiology guidelines for the diagnosis and
treatment of acute and chronic heart failure [7] provide
remote monitoring with a IIb recommendation and level
of evidence C, indicating that the usefulness or efficacy of
remote monitoring is less well established by evidence
and opinion, and that the evidence for remote monitor-
ing practices is the consensus of opinion of the experts
and/or small studies, not clinical trials.
Implications for clinical practice
Health care has developed around a direct encounter
between the patient and the professional that involves
verbal and non-verbal communication and the exchange
of information. Remote monitoring therefore alters
traditional models of health care delivery and requires
organisational change within the health care system for
its full potential to be achieved. Nurses usually play a
central role in successful remote monitoring initiatives.
Remote monitoring practices vary in important compo-
nents, such as the amount and type of clinical informa-
tion transmitted and the patient’si n v o l v e m e n ti n
self-monitoring. To fully understand their effectiveness,
evaluation should address the process alongside the
outcome. Greater clarity over the use of the term would
also be valuable when assessing the effectiveness of
remote monitoring.
Wider evaluation of these new and complex models of
care delivery is required that goes beyond the current
reporting of clinical effectiveness. Before such socially
complex interventions are routinely adopted we would
be wise to evaluate their effect on morbidity, the health
care organisation involved and upon patient-centred
outcomes.
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